Mast Cell Chymase and Tryptase as Targets for Cardiovascular and Metabolic Diseases

E-ISSN： 1873-4286|19|6|1114-1125

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.6, 2013-02, pp. : 1114-1125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging therapeutic targets in asthma: the rationale for mast cell tryptase inhibition

By Elrod K.C. Numerof R.P.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 2, 1999-06 ,pp. : 203-212

Informa Healthcare

Access to resources Recommend Favorite

PPARs as Targets for Metabolic and Cardiovascular Diseases

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 8, 2005-08 ,pp. : 741-753

Bentham Science Publishers

Access to resources Recommend Favorite

The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors

By He S. Gaca M.D.A. Walls A.F.

European Journal of Pharmacology, Vol. 412, Iss. 3, 2001-02 ,pp. : 223-229

Elsevier

Access to resources Recommend Favorite

Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation

By He S. Walls A.F.

European Journal of Pharmacology, Vol. 328, Iss. 1, 1997-09 ,pp. : 89-97

Elsevier

Access to resources Recommend Favorite

Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas

By Muramatsu M. Katada J. Hattori M. Hayashi I. Majima M.

European Journal of Pharmacology, Vol. 402, Iss. 1, 2000-08 ,pp. : 181-191

Elsevier

Access to resources Recommend Favorite